These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29334271)

  • 1. The safety of available treatments of male hypogonadism in organic and functional hypogonadism.
    Corona G; Rastrelli G; Reisman Y; Sforza A; Maggi M
    Expert Opin Drug Saf; 2018 Mar; 17(3):277-292. PubMed ID: 29334271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological management of late-onset hypogonadism.
    Rastrelli G; Maggi M; Corona G
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):439-458. PubMed ID: 29505313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone Therapy: What We Have Learned From Trials.
    Corona G; Torres LO; Maggi M
    J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on heart disease risk associated with testosterone boosting medications.
    Corona G; Rastrelli G; Guaraldi F; Tortorici G; Reismann Y; Sforza A; Maggi M
    Expert Opin Drug Saf; 2019 Apr; 18(4):321-332. PubMed ID: 30998433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis.
    Corona G; Rastrelli G; Sparano C; Carinci V; Casella G; Vignozzi L; Sforza A; Maggi M
    Expert Opin Drug Saf; 2024 May; 23(5):565-579. PubMed ID: 38553429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular impact of testosterone therapy for hypogonadism.
    Rastrelli G; Dicuio M; Reismann Y; Sforza A; Maggi M; Corona G
    Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):617-625. PubMed ID: 30099911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging medication for the treatment of male hypogonadism.
    Aydogdu A; Swerdloff RS
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacotherapy of male hypogonadism besides androgens.
    Corona G; Rastrelli G; Maggi M
    Expert Opin Pharmacother; 2015 Feb; 16(3):369-87. PubMed ID: 25523084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis.
    Cui Y; Zong H; Yan H; Zhang Y
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):132-43. PubMed ID: 24445948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
    Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
    Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
    Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
    Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).
    Maggi M; Wu FC; Jones TH; Jackson G; Behre HM; Hackett G; Martin-Morales A; Balercia G; Dobs AS; Arver ST; Maggio M; Cunningham GR; Isidori AM; Quinton R; Wheaton OA; Siami FS; Rosen RC;
    Int J Clin Pract; 2016 Oct; 70(10):843-852. PubMed ID: 27774779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of hypogonadism in adult males].
    Köhn FM
    Hautarzt; 2004 Sep; 55(9):877-895; quiz 896-7. PubMed ID: 15484339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
    Magnussen LV
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on male hypogonadism therapy.
    Surampudi P; Swerdloff RS; Wang C
    Expert Opin Pharmacother; 2014 Jun; 15(9):1247-64. PubMed ID: 24758365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
    Chrysant SG; Chrysant GS
    Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone replacement therapy and cardiovascular events.
    Çatakoğlu AB; Kendirci M
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in testosterone therapy for men.
    Corona G; Rastrelli G; Forti G; Maggi M
    J Sex Med; 2011 Mar; 8(3):639-54; quiz 655. PubMed ID: 21711483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.